This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignees: Kinki University, Kobayashi Pharmaceutical Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2023
Title: Tomoya Takeda: Innovator in Neuropathy Treatment
Introduction
Tomoya Takeda is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medical science, particularly in the treatment of peripheral sensory neuropathy. His innovative approach addresses a critical need for effective therapies for patients suffering from drug-induced neuropathy.
Latest Patents
Tomoya Takeda holds a patent for a composition aimed at ameliorating peripheral sensory neuropathy. This condition often arises as a side effect of anticancer drugs, such as oxaliplatin. His patented composition includes amycelium extract, which has shown promise in alleviating symptoms like numbness, pain in extremities, and impaired motor functions. This breakthrough offers hope for patients who have limited treatment options available.
Career Highlights
Throughout his career, Takeda has worked with esteemed institutions, including Kinki University and Kobayashi Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Tomoya Takeda has collaborated with notable colleagues, including Kiyotaka Okuno and Satoshi Wachi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of neuropathy treatment.
Conclusion
Tomoya Takeda's work in developing a composition for treating peripheral sensory neuropathy highlights his commitment to improving patient care. His innovative solutions and collaborations with other experts in the field continue to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile